Check out the companies that make headlines in pre-market transactions. Disney – The media and entertainment company’s shares rose more than 7% after surpassing Wall Street’s second-quarter estimates. Disney reported adjusted earnings of $1.45 per share with revenue of $23.62 billion, while analysts voted by LSEG were looking for $1.20 and $23.14 billion per share, respectively. The company also raised its annual revenue outlook to $5.75 per share, but Wall Street was looking for $5.43 per share. Separately, Disney has agreed to partner with Miral to build a theme park and resort in Abu Dhabi. Super Microcomputer – Shares have retreated more than 6% after server makers missed third quarter forecasts and offered weak guidance this quarter. Super Micro posted adjusted revenue of 31 cents per share with revenue of $4.6 billion, while analysts surveyed by LSEG supplied pencils at 50 cents per share and revenue of $5.42 billion. Wynn Resorts – The hotel and casino company shares rose about 3% after an upgrade to buy from Bank of America’s neutral, focusing on the Middle Eastern company’s casino projects. The move came despite Wynn’s first quarter report, which showed weak results in Macau. Las Vegas revenues experienced a smaller decline. According to LSEG, Wynn has earned $1.07 per share, adjusting its most recent quarter. Logitech – Computer Accessories Company inventory has increased by more than 1% after an upgrade to purchase from UBS. Analyst Joern Iffert suggested that stocks have already been actively pulling back and could represent an attractive entry point for investors. Uber Technologies – Shares fell 3%, missing the $11.62 billion LSEG consensus after the ride-sharing company reported revenue of $11.53 billion in the first quarter. However, Uber’s revenues have surpassed expectations. Advanced Micro Devices – Chipmaker stocks won over 1% following a stronger than expected First Qualto results. AMD earned 96 cents per share with revenue of $7.444 billion, while analysts forecast LSEG’s forecast of 94 cents per cent, or $7.13 billion. Novo Nordisk – The US trading stock of the Danish drug maker has moved forward nearly 5% after saying that weight loss drug sales are growing later this year as the combined drugs have been phased out. Sarepta Therapeutics – After a sharp loss in the first quarter, the stock fell 18%, cutting its full-year net product revenue forecast to the $230 million range from $2.6 billion. Analysts voted by FactSet were looking for the indicator to be between $2.9 billion and $31 billion. Upstart Holdings – Stock in the Artificial Intelligence Loan Platform fell 17% after narrowly violating Wall Street’s revenue outlook for both the annual and current quarter. The company issued beats in the first quarter at the top and bottom line. – Hakyung Kim, Michelle Fox, Jesse Pound and Sean Conlon of CNBC contributed the report.